SOLICITATION NOTICE
65 -- Autoflouresence Bronchoscopy System
- Notice Date
- 2/11/2009
- Notice Type
- Presolicitation
- NAICS
- 339112
— Surgical and Medical Instrument Manufacturing
- Contracting Office
- Department of the Navy, Bureau of Medicine and Surgery, NMLC, 1681 Nelson St, FT Detrick, Maryland, 21702-9203
- ZIP Code
- 21702-9203
- Solicitation Number
- N6264509RCES075
- Archive Date
- 3/7/2009
- Point of Contact
- Erin M Cotter, Phone: 301-619-1086, Burzie C Baker III,, Phone: 301-619-0707
- E-Mail Address
-
erin.cotter@med.navy.mil, burzie.baker@med.navy.mil
- Small Business Set-Aside
- N/A
- Description
- The Naval Medical Logistics Command intends to negotiate on a sole source basis (IAW FAR 13.501) with NOVADAQ Corporation, 11091 Corsia Trieste Way Unit 201, Bonita Springs, FL, 34135, as the only responsible source that can provide an autofluorescence bronchoscopy system that is compatible with the currently installed base of Olympus endoscopes at the requesting facility. The requirement is for an autofluorescence bronchoscopy system. The system shall consist of a light source, camera, camera controller, footswitch, lamp cartridges with lamps, four BNC cables, and two power cords. The system shall have the ability to detect and localize cancerous and precancerous tissue for biopsy and further evaluation during endoscopy using a light source color inconsistency. The system shall operate in two imaging modes: conventional white light imaging mode and fluorescence imaging mode. The system shall be compatible with the installed base of Olympus endoscopes (specifically bronchoscopes). The electrical requirements are 120 VAC, 60Hz. Regulatory Requirements: The system and all of the components, shall be compliant with the Food and Drug Administration (FDA) requirements to market and deliver medical products for use in the United States of America, even should delivery be requested outside of the United States. The claims made for the product shall comply with the regulations of the FDA with respect to products for marketing and delivery of a medical product for use in the United States of America, even should delivery be requested outside of the United States. This acquisition is being conducted under simplified acquisition procedures FAR 13.501 under the authority of the test program for commercial items (section 4202 of the Clinger-Cohen Act of 1996). There are not set-aside restrictions for this requirement. The intended procurement will be classified under North America Industry Classification System (NAICS) 339112. This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement. However, parties interested in responding to this notice will need to submit technical data, including cost, sufficient to determine capability in providing the same product. All capability statements received by the closing date of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Capability statements shall be submitted by email only as a MS Word or Adobe PDF attachment to Erin.Cotter@med.navy.mil. No phone calls accepted.
- Web Link
-
FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=0253cbb368136b1ac71a618899bb7c39&tab=core&_cview=1)
- Place of Performance
- Address: National Naval Medical Center, Bldg 01, 8901 Wisconsin Ave, Bethesda, Maryland, 20889, United States
- Zip Code: 20889
- Zip Code: 20889
- Record
- SN01749116-W 20090213/090211221149-0253cbb368136b1ac71a618899bb7c39 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |